Skip to main content
Kolinpharma logo

Kolinpharma — Investor Relations & Filings

Ticker · KIP ISIN · IT0005322950 LEI · 815600FC8F1A3BED2743 XMIL Manufacturing
Open in API
Filings indexed 222 across all filing types
Latest filing 2023-09-27 Delisting Announcement
Country IT Italy
Listing XMIL KIP

About Kolinpharma

https://www.kolinpharma.com/index-en

Kolinpharma is a nutraceutical company established in 2013, specializing in the research and development of innovative products designed to improve well-being and quality of life. The company's core activities are centered on scientific research and product innovation, creating high-quality nutraceuticals. It operates an in-house R&D department and collaborates with leading universities for in-vitro and clinical studies. As a certified B Corporation, Kolinpharma adheres to high standards of social and environmental performance. The company distributes its proprietary branded products through a qualified network of medical-scientific representatives.

Recent filings

Filing Released Lang Actions
KOLINPHARMA-Opa volontaria promossa da Igea holding-Esito procedura congiunta e Delisting_27_09_2023
Delisting Announcement Classification · 99% confidence The document is an official communication from Kolinpharma S.p.A. regarding an 'OFFERTA PUBBLICA DI ACQUISTO VOLONTARIA TOTALITARIA' (Voluntary Total Takeover Bid) promoted by Igea Holding S.p.A. The key subject is the execution of the joint procedure for the purchase of the remaining shares and the subsequent 'REVOCA DALLE NEGOZIAZIONI DELLE AZIONI' (Revocation from trading of the shares) effective on the date of the announcement (September 27, 2023). This action—the compulsory purchase of remaining shares following a successful takeover bid, leading directly to delisting—is a significant corporate action related to capital structure and market status. Reviewing the definitions: - 10-K/IR/ER/AR: Not a periodic financial report. - CAP: While related to financing, the core event is the finalization of the takeover and the resulting delisting. - TAR (M&A Activity): This is highly relevant as it concludes a takeover process. However, the most specific outcome announced here is the delisting. - DLST (Delisting Announcement): The document explicitly states the 'REVOCA DALLE NEGOZIAZIONI DELLE AZIONI' (Revocation from trading) effective immediately, which is the definition of a delisting announcement. Since the primary, immediate, and final action being communicated is the removal of the stock from the exchange following the mandatory buy-out procedure, DLST (Delisting Announcement) is the most precise classification, even though it stems from a prior M&A event (TAR). The document serves as the official notice of the delisting. The document length (8503 chars) is substantial, so it is not an RPA/RNS based on the 'MENU VS MEAL' rule.
2023-09-27 Italian
KOLINPHARMA, Opa volontaria promossa da Igea Holding, risultati definitivi della procedura di sell-out
M&A Activity Classification · 98% confidence The document is an official communication titled "OFFERTA PUBBLICA DI ACQUISTO VOLONTARIA TOTALITARIA PROMOSSA DA IGEA HOLDING S.P.A. SULLE AZIONI DI KOLINPHARMA S.P.A. RISULTATI DEFINITIVI DELLA PROCEDURA DI SELL-OUT". This clearly indicates an announcement regarding the final results of a mandatory/voluntary takeover bid (Offer/Procedura di Sell-Out) under Italian financial law (TUF articles 102, 106, 108, 111). This type of corporate action, involving the acquisition of shares following a tender offer and subsequent squeeze-out/sell-out procedures, falls under the category of M&A Activity (Takeover/Merger Activity). Although the document also mentions the subsequent delisting, the primary focus and content detail the results of the tender offer/sell-out procedure, which aligns best with the 'M&A Activity' definition (Code: TAR). It is a definitive announcement of results, not just a general regulatory filing (RNS) or a report publication announcement (RPA), as it contains substantive transactional data.
2023-09-18 Italian
Kolinpharma-Opa volontaria promossa da Igea Holding-Risultati provvisori della procedura di sell-out
M&A Activity Classification · 99% confidence The document is an official communication titled "RISULTATI PROVVISORI DELLA PROCEDURA DI SELL-OUT" (Provisional Results of the Sell-Out Procedure) concerning a voluntary takeover bid (Offerta Pubblica di Acquisto Volontaria Totalitaria) for Kolinpharma S.p.A. shares by Igea Holding S.p.A. It details the provisional results of the mandatory buy-out procedure (Procedura di Sell-Out) under Italian law (TUF articles 108, 111). This type of announcement, detailing the outcome or status of a significant corporate transaction like a takeover bid, fits best under Capital/Financing Update (CAP) as it directly relates to a major change in capital structure and ownership transfer, or potentially Regulatory Filings (RNS) if no other category is suitable. Since it details the results and next steps of a tender offer/buyout, which is a major financing/capital event, CAP is a strong candidate. However, given the specific nature of reporting the results of a mandatory buy-out following a takeover, which is a highly regulated corporate action, and considering the available codes, 'CAP' (Capital/Financing Update) covers fundraising and capital structure changes well. If the document were purely announcing the *intention* to launch an offer, TAR (M&A Activity) might apply, but this is reporting the *results* of the final stage (Sell-Out). Since it is a formal regulatory disclosure about the finalization of a change in control and capital structure, CAP is the most appropriate fit among the provided options for a detailed result announcement of a financing/acquisition event, although RNS is a possibility if CAP is too broad. Given the focus on share acquisition and resulting capital structure change, CAP is selected.
2023-09-15 Italian
Kolinpharma-Opa volontaria promossa da Igea holding-Acquisti e superamento soglia del 95% (14.09.2023)
M&A Activity Classification · 98% confidence The document is an official communication titled "OFFERTA PUBBLICA DI ACQUISTO VOLONTARIA TOTALITARIA PROMOSSA DA IGEA HOLDING S.P.A. SULLE AZIONI DI KOLINPHARMA S.P.A." (Voluntary Total Takeover Bid promoted by Igea Holding S.p.A. on the shares of Kolinpharma S.p.A.). It discusses the acquisition of shares, reaching the 95% threshold required for the mandatory purchase right (Diritto di Acquisto) under Italian law (Art. 111 TUF), and references the ongoing Sell-Out Procedure. This clearly relates to a corporate action involving a takeover bid and subsequent capital structure changes/acquisitions. This falls under the category of M&A Activity (TAR) or potentially Capital/Financing Update (CAP). Since the core subject is the takeover bid ('Offerta Pubblica di Acquisto') and the resulting acquisition of shares leading to a mandatory buy-out, 'M&A Activity' (TAR) is the most precise classification. It is not a general regulatory filing (RNS) because it is highly specific to a takeover.
2023-09-14 Italian
Kolinpharma-Opa volontaria promossa da Igea Holding-Acquisti fuori Opa 13_09_2023
M&A Activity Classification · 98% confidence The document is an official communication from Kolinpharma S.p.A. (via Igea Holding S.p.A.) regarding an ongoing Tender Offer ('OFFERTA PUBBLICA DI ACQUISTO VOLONTARIA TOTALITARIA'). Specifically, the subject line and text detail 'ACQUISTI FUORI OPA' (Purchases outside the Tender Offer) made on September 13, 2023, and updates the total shareholding percentage (reaching 94.541%). This type of corporate action, involving tender offers, share acquisitions, and capital structure movements related to a takeover/acquisition process, falls under the scope of Merger & Acquisition (M&A) activity or significant capital changes. Given the explicit focus on the tender offer mechanics, share purchases outside the offer, and the resulting ownership percentage, the most appropriate classification is Transaction in Own Shares (POS) if it were just a buyback, or M&A Activity (TAR) due to the context of the takeover bid. Since the core event is the update related to the ongoing takeover/acquisition process (Offerta Pubblica di Acquisto), TAR (Merger & Acquisition Activity) is the best fit, as it covers proposals and takeover bids. It is not a general financing update (CAP) but a specific transaction related to gaining control.
2023-09-14 Italian
Kolinpharma-Opa volontaria promossa da Igea holding Spa-acquisti fuori opa 11-09-2023
M&A Activity Classification · 98% confidence The document is an official communication from Kolinpharma S.p.A. (via Igea Holding S.p.A.) regarding an 'OFFERTA PUBBLICA DI ACQUISTO VOLONTARIA TOTALITARIA' (Voluntary Total Takeover Bid) and specifically details 'ACQUISTI FUORI OPA' (Purchases outside the tender offer period). This involves the acquisition and ownership changes of company shares related to a takeover process. This clearly falls under corporate actions related to capital structure and ownership changes, specifically a takeover/merger activity. The most fitting category is M&A Activity (TAR), as it directly concerns the mechanics and results of a takeover bid (OPA). It is not a general financing update (CAP) but a specific transaction related to acquiring control.
2023-09-11 Italian

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.